Clinical Trial Update: Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is underway to compare NAD precursors for potential neuroprotection in patients with glaucoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• NAD precursors (NAD precursor)

Snippet

Sponsor: Christopher Kai Shun Leung | Conditions: Glaucoma | Phase 2 | Status: RECRUITING